Stock search

Ticker or company name

Compare stocks

Market: US

  • VEEVVeeva Systems
  • HUMHumana
  • IDXXIdexx Laboratories

Add stock

Ticker or company

Summary

VEEV
Veeva Systems
$299,28Down −0,75%
Year: Up +3%
89/100Best scoreRatio would consider buying
Open stock page
HUM
Humana
$461,25Up +2,50%
Year: Up +90%
61/100Ratio would watch
Open stock page
IDXX
Idexx Laboratories
$700,65Down −0,51%
Year: Up 0%
83/100Ratio would consider buying
Open stock page

Verdict

VEEV has the best score (89). HUM grows revenue the fastest. HUM is the cheapest by forward P/E. VEEV has the lowest debt load. VEEV has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckVEEV8 ✓ 0 — 1 ✕HUM5 ✓ 1 — 3 ✕IDXX7 ✓ 1 — 1 ✕
P/E vs its history47,344,047,2
P/E vs industry47,344,047,2
Forward P/E33,626,933,5
Revenue growth, YoY+16,5%+22,0%+11,9%
EPS growth, YoY+25,7%−3,6%+17,7%
Net margin29,3%0,8%25,4%
Net debt / EBITDA−7,0−4,50,1
Free cash flow$1,67 bn$3,14 bn$1,30 bn
Share count over a year−1,6%+0,9%−2,0%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterVEEVTTMHUMTTMIDXXTTMIndustry medianTTM
P/E TTM ↓Worst: 47,3Best: 44,047,225,1
Forward P/E ↓Worst: 33,6Best: 26,933,516,2
PEG ↓2,1Best: 1,9Worst: 2,82,2
P/S TTM ↓Worst: 13,9Best: 0,412,02,2
EV/EBITDA ↓Worst: 43,2Best: 20,033,917,3
P/FCF ↓29,3Best: 11,0Worst: 42,919,5

Price, %

  • VEEVn/a
  • HUMn/a
  • IDXXn/a

Returns

Best WorstNo mark — in between

PeriodVEEVHUMIDXX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

VEEVHUMIDXX
Share of “buy”Best: 74%Worst: 59%67%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”Worst: +3,4%Best: +9,4%+3,7%
Insiders over 12 monthssales $16,8 msales $2,43 msales $58,4 m

Details are on each stock page.